BiotechTube

Humalog Mix25 + Insulin Lispro Biphasic 25

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Diabetes Mellitus, Type 2

Conditions

Diabetes Mellitus, Type 2, Diabetes Mellitus

Trial Timeline

Mar 14, 2018 → Apr 18, 2019

NCT ID
NCT04023344

About Humalog Mix25 + Insulin Lispro Biphasic 25

Humalog Mix25 + Insulin Lispro Biphasic 25 is a phase 3 stage product being developed by GEROPHARM for Diabetes Mellitus, Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT04023344. Target conditions include Diabetes Mellitus, Type 2, Diabetes Mellitus.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT04023344Phase 3Completed

Competing Products

20 competing products in Diabetes Mellitus, Type 2

See all competitors
ProductCompanyStageHype Score
add-on pioglitazone + add-on sulphonylureaAMD BiotechApproved
77
MKP10241 + PlaceboMankind PharmaPhase 2
52
Daily injection of KBP/placebo for up to 28 daysEli LillyPhase 1
33
LY3209590 + Insulin DegludecEli LillyPhase 1
33
AC2993Eli LillyPhase 3
77
LY3209590 + PlaceboEli LillyPhase 1
33
Insulin Lispro Protamine Suspension + Insulin GlargineEli LillyPhase 3
77
LY2963016 + LantusEli LillyPhase 1
33
Empagliflozin + Other SGLT2 inhibitors + Other non-insulin GLDsEli LillyPre-clinical
23
Insulin Lispro Mix25 + Insulin Lispro Mix50Eli LillyApproved
85
Nasal Glucagon + Intramuscular GlucagonEli LillyPhase 3
77
Retatrutide + PlaceboEli LillyPhase 1
33
AG019 - Low Dose + Teplizumab + Placebo-AG019 + Placebo-Teplizumab + AG019 - High Dose + AG019 - High DosePrecigenPhase 1/2
36
LY4057996 SC + LY4057996 IV + Placebo SC + Placebo IV + Degludec SC + Lispro SC + Degludec IV + Pre-study basal insulin SCEli LillyPhase 1
33
Placebo + LinagliptinEli LillyPhase 3
77
Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Eli LillyApproved
85
teplizumab or placeboEli LillyPhase 1
33
LY2428757 + PlaceboEli LillyPhase 2
52
Insulin Efsitora Alfa + Insulin DegludecEli LillyPhase 3
77
LY900014 (SC) + LY900014 (IV)Eli LillyPhase 1
33

Other Products from GEROPHARM

Lantus Solostar, 100 Units/mL Subcutaneous Solution + Insulin RinGlar, 100 Units/mL Subcutaneous SolutionPhase 3
69
GP404141 + NplatePhase 3
69
GP40081 + NovoMix 30Phase 3
69
GP40071 + NovoRapid® Penfill®Phase 3
69
GP40321 + Apidra® SoloStar® + RinGlar®Phase 3
69